FTT
Click for more information
0.00% 0.5¢ factor therapeutics limited

From Marc Sinatra (lodge partners) on Twitter: "Just released a...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Werble
    494 Posts.
    lightbulb Created with Sketch. 53
    clock Created with Sketch.
    16/07/18
    13:42
    Post #: 34368615
    From Marc Sinatra (lodge partners) on Twitter: "Just released a report on Factor Therapeutics $FTT. Looks highly undervalued. NPV = 33.5 cents/share (fully diluted) prior to phase IIb readout in Q4 CY18. NPV = 52 cents after, if +ve. Multiple catalysts to get it there. It’s a good one! @biotech_daily @asxlongtail @Factor_Tx"
    FTT Price at posting: 6.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.